Estelle Vautrin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Estelle Vautrin has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
G. Barone-Rochette
Clinique de cardiologie, CHU de Grenoble, BP 217, 38043 Grenoble cedex 09, France; Inserm, U1039, radiopharmaceutiques biocliniques, 38043 Grenoble cedex 09, France
6 shared publicationsJ.-P. Baguet
3 shared publicationsL. Boggetto-Graham
3 shared publicationsO. Chavanon
3 shared publicationsF. Thony
2 shared publicationsH. Pierre
2 shared publications
Latest Publications
- Open Access
- 14 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (6) , 1681
The RISE Study: Retrospective Registry for the International Safety and Efficacy Results of Patent Foramen Ovale Closure with Figulla Flex Il PFO and UNI Occluders
Background: Transcatheter closure of a patent foramen ovale (PFO) is performed in cryptogenic stroke and other conditions. Information is lacking for some devices. Methods: We aimed to evaluate the Figulla Flex II PFO Occluder (FFP) and Figulla Flex UNI Occluder (FFU) through a retrospective multi-center registry. Results: 527 patients were included. Mean age was 48.9 (±13.8) years. The procedure was under transthoracic, transesophageal or intracardiac echocardiography in 185 (35.1%), 193 (36.6%) and 149 (28.3%) cases, respectively, and under general anesthesia in 191 patients (36.2%). The FFP and FFU were used in 408 (77.4%) and 119 (22.6%) cases, respectively. The success rate was 99.1%. Median follow-up was 1.1 (0.5–2.5) years. A new atrial fibrillation/flutter within six months occurred in 14 (2.7%) cases, with no difference between devices. One device embolization in the pulmonary artery was identified two years post-procedure. Residual shunts occurred in 18 (6.9%) cases at 1 year, with TIA in three (16.6%) patients. Out of 437 patients with stroke/TIA, 260 (59%) were followed more than one year after closure. Median follow-up was 2.1 (1.17–3.1) years, with four recurrent strokes/TIA. Conclusions: The FFP and FFU devices are safe and effective for PFO closure, with very few atrial fibrillation/flutter and neurologic events, except in cases with a residual shunt.
- 14 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (6) , 1681
Open AccessThe RISE Study: Retrospective Registry for the International Safety and Efficacy Results of Patent Foramen Ovale Closure with Figulla Flex Il PFO and UNI Occluders
Background: Transcatheter closure of a patent foramen ovale (PFO) is performed in cryptogenic stroke and other conditions. Information is lacking for some devices. Methods: We aimed to evaluate the Figulla Flex II PFO Occluder (FFP) and Figulla Flex UNI Occluder (FFU) through a retrospective multi-center registry. Results: 527 patients were included. Mean age was 48.9 (±13.8) years. The procedure was under transthoracic, transesophageal or intracardiac echocardiography in 185 (35.1%), 193 (36.6%) and 149 (28.3%) cases, respectively, and under general anesthesia in 191 patients (36.2%). The FFP and FFU were used in 408 (77.4%) and 119 (22.6%) cases, respectively. The success rate was 99.1%. Median follow-up was 1.1 (0.5–2.5) years. A new atrial fibrillation/flutter within six months occurred in 14 (2.7%) cases, with no difference between devices. One device embolization in the pulmonary artery was identified two years post-procedure. Residual shunts occurred in 18 (6.9%) cases at 1 year, with TIA in three (16.6%) patients. Out of 437 patients with stroke/TIA, 260 (59%) were followed more than one year after closure. Median follow-up was 2.1 (1.17–3.1) years, with four recurrent strokes/TIA. Conclusions: The FFP and FFU devices are safe and effective for PFO closure, with very few atrial fibrillation/flutter and neurologic events, except in cases with a residual shunt.
- 1 December 2016
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 65 (6) , 404-410
Coronaropathie de la femme : rôle des hormones sexuelles
- 1 December 2016
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 65 (6) , 404-410
Coronaropathie de la femme : rôle des hormones sexuelles
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e143
PP.02.14
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e143
PP.02.14
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e38-e39
3C.07
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e38-e39
3C.07
- 1 January 2015
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 32, A34
Impact du SAOS dans l’évolution de la pathologie anévrismale aortique
- 1 January 2015
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 32, A34
Impact du SAOS dans l’évolution de la pathologie anévrismale aortique
- 12 December 2014
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 16 (2) , 229
First magnetic resonance coronary artery imaging of bioresorbable vascular scaffold in-patient
Figure 1 Stress P-CMR imaging (A: base slice; B: mid-slice; and C: apical slice) and MRCA were reported normal; coronary angiogram confirmed no in-stent restenosis of BVS. The arrows delimit the stenosis and BVS implanted. BVS, bioresorbable vascular scaffold; ICA, invasive coronary angiography; MRCA, magnetic resonance coronary artery imaging; P-CMR, perfusion cardiac magnetic resonance.
- 12 December 2014
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 16 (2) , 229
First magnetic resonance coronary artery imaging of bioresorbable vascular scaffold in-patient
Figure 1 Stress P-CMR imaging (A: base slice; B: mid-slice; and C: apical slice) and MRCA were reported normal; coronary angiogram confirmed no in-stent restenosis of BVS. The arrows delimit the stenosis and BVS implanted. BVS, bioresorbable vascular scaffold; ICA, invasive coronary angiography; MRCA, magnetic resonance coronary artery imaging; P-CMR, perfusion cardiac magnetic resonance.
- 1 June 2012
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 61 (3) , 203-208
Dissection aortique étendue aux artères rénales : intérêt de la volumétrie rénale après angioplastie
- 1 June 2012
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 61 (3) , 203-208
Dissection aortique étendue aux artères rénales : intérêt de la volumétrie rénale après angioplastie
- 1 June 2011
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 29, e478
PREDICTIVE PARAMETERS FOR PROGRESSION OF AORTIC DIAMETER AFTER SURGERY FOR TYPE A AORTIC DISSECTION OR HAEMATOMA
- 1 June 2011
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 29, e478
PREDICTIVE PARAMETERS FOR PROGRESSION OF AORTIC DIAMETER AFTER SURGERY FOR TYPE A AORTIC DISSECTION OR HAEMATOMA
- 1 June 2011
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 29, e251-e252
BLOOD PRESSURE MANAGEMENT IS INADEQUATE AFTER SURGERY FOR ACUTE TYPE A AORTIC SYNDROME
- 1 June 2011
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 29, e251-e252
BLOOD PRESSURE MANAGEMENT IS INADEQUATE AFTER SURGERY FOR ACUTE TYPE A AORTIC SYNDROME